logo

Principia Biopharma Inc. (PRNB)



Trade PRNB now with
  Date
  Headline
9/22/2020 1:03:18 AM Sanofi Says HSR Waiting Period Expires For Acquisition Of Principia Biopharma
9/17/2020 8:19:37 AM Principia Biopharma Announces First Patient Dosed In Phase 2A Trial Of Rilzabrutinib In IgG4-Related Disease
8/28/2020 1:22:33 AM Sanofi Intends To Commence Tender Offer To Acquire Principia Biopharma
6/23/2020 1:40:21 AM Principia Biopharma Says First Patient Enrolled In Sanofi’s Phase 3 Trial Of SAR442168 In Relapsing Multiple Sclerosis
3/10/2020 4:06:01 PM Principia Biopharma Q4 Loss/share $0.80 Vs. Profit $0.37 Year Ago
10/15/2019 10:54:22 PM Principia Biopharma Prices Public Offering Of 7.50 Mln Shares At $28.00/shr
10/15/2019 4:03:31 PM Principia Announces Proposed Public Offering Of Common Stock
10/15/2019 7:11:21 AM Principia Announces Positive Preliminary Data From Phase 1/2 Trial Of PRN1008 For Immune Thrombocytopenia
7/30/2019 8:30:36 AM Principia Announces Update To Ongoing Phase 2 Clinical Trial In Patients With ITP
10/24/2018 8:06:49 AM Principia Biopharma Appoints Dolca Thomas As Chief Medical Officer
10/19/2018 8:09:52 AM Principia Biopharma: PRN1008 Receives Orphan-Drug Designation From FDA